Effects on Ocular Parameters of Myopic Eyes After Orthokeratology in Myopic Children
NCT ID: NCT03516357
Last Updated: 2018-05-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2018-01-11
2022-01-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Orthokeratography on the Quality of Life and Behavior of Myopic Children
NCT05956717
Investigating the Safety and Effect of Overnight Orthokeratology and Its Influencing Factors
NCT04910451
The Effect of Treatment Zone Decentration on Axial Length Elongation After Orthokeratology
NCT05365373
Comparing Myopia Treatments in Youth: Defocus Spectacles, Glasses, and Ortho-K
NCT06278974
Effect of Orthokeratology Versus Spectacles on Myopia Progression in Chinese Children: A Crossover Trial
NCT02186184
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
low myopia
-3.00D \< spherical equivalent refractive error \< -0.50D
No interventions assigned to this group
moderate myopia
-6.00D \< spherical equivalent refractive error ≤ -3.0D
No interventions assigned to this group
high myopia
spherical equivalent refractive error ≤ -6.0D
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
8 Years
15 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Eye Disease Prevention and Treatment Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shanghai Eye Disease Prevention & Treatment Center
Shanghai, Jingan, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Zhu Mengjun, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
YFZX2017002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.